Gori, S., Rossi, V., Turazza, M., Fiorio, E., Fabi, A., Bisagni, G., et al. (2015). Multi-institutional retrospective analysis of clinical and pathological factors predicting resistance to lapatinib-based therapy in HER2 positive metastatic breast cancer (HER2+ MBC). In 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium. AMER ASSOC CANCER RESEARCH [10.1158/1538-7445.SABCS14-P5-19-25].

Multi-institutional retrospective analysis of clinical and pathological factors predicting resistance to lapatinib-based therapy in HER2 positive metastatic breast cancer (HER2+ MBC)

Zambelli A;
2015

abstract
Oncology
English
37th Annual CTRC-AACR San Antonio Breast Cancer Symposium - DEC 09-13, 2014
2014
37th Annual CTRC-AACR San Antonio Breast Cancer Symposium
2015
75
S9
P5-19-25
none
Gori, S., Rossi, V., Turazza, M., Fiorio, E., Fabi, A., Bisagni, G., et al. (2015). Multi-institutional retrospective analysis of clinical and pathological factors predicting resistance to lapatinib-based therapy in HER2 positive metastatic breast cancer (HER2+ MBC). In 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium. AMER ASSOC CANCER RESEARCH [10.1158/1538-7445.SABCS14-P5-19-25].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/560564
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact